Documents
Application Sponsors
BLA 761181 | REGENERON PHARMACEUTICALS | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | SOLUTION; INJECTION | 345MG/2.3ML | 0 | EVKEEZA | EVINACUMAB-DGNB |
002 | SOLUTION; INJECTION | 1200MG/8ML | 0 | EVKEEZA | EVINACUMAB-DGNB |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 2021-02-11 | PRIORITY |
Submissions Property Types
CDER Filings
REGENERON PHARMACEUTICALS
cder:Array
(
[0] => Array
(
[ApplNo] => 761181
[companyName] => REGENERON PHARMACEUTICALS
[docInserts] => ["",""]
[products] => [{"drugName":"EVKEEZA","activeIngredients":"EVINACUMAB-DGNB","strength":"345MG\/2.3ML","dosageForm":"SOLUTION; INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"EVKEEZA","activeIngredients":"EVINACUMAB-DGNB","strength":"1200MG\/8ML","dosageForm":"SOLUTION; INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"02\/11\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/761181s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"02\/11\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A; Orphan","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/761181s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/761181Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2021-02-11
)
)